Praxis Precision Medicines, Inc. (PRAX) stock
PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$328.13+3.37 (+1.04%)
Close on Nov 13, 2026Market cap $9.16BP/E –Yield –
Praxis Precision Medicines profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Praxis Precision Medicines's profit margin for the twelve months ending Sep 30, 2025 was -3658.5%. For fiscal 2024 it was -2137.5%, against -5037.9% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -2137.5% | +2900.4 |
| FY2023 | Dec 31, 2023 | -5037.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -786.3% | +4432.8 |
| Q3 FY2024 | Sep 30, 2024 | -17188.7% | −11925.5 |
| Q2 FY2024 | Jun 30, 2024 | -9153.2% | −4759.9 |
| Q1 FY2024 | Mar 31, 2024 | -9177.0% | −3693.1 |
| Q4 FY2023 | Dec 31, 2023 | -5219.0% | – |
| Q3 FY2023 | Sep 30, 2023 | -5263.2% | – |
| Q2 FY2023 | Jun 30, 2023 | -4393.3% | – |
| Q1 FY2023 | Mar 31, 2023 | -5483.9% | – |
See a number that looks wrong?